1-demethyl Phenazolam is primarily utilized in research settings for its potential pharmacological properties. It is often studied for its effects on the central nervous system, particularly in relation to its interaction with GABA receptors, which are crucial for modulating anxiety, sedation, and muscle relaxation. Researchers explore its potential as a precursor or analog in the development of novel therapeutic agents targeting anxiety disorders, insomnia, or other conditions related to GABAergic activity. Additionally, it may be used in analytical chemistry as a reference compound for identifying and characterizing similar benzodiazepine derivatives in forensic or toxicological studies. Its application remains largely confined to experimental and investigative contexts, with no widespread clinical use at present.